Literature DB >> 19782480

Examining differential effects of psychosocial treatments for cocaine dependence: an application of latent trajectory analyses.

Niklaus Stulz1, Robert Gallop, Wolfgang Lutz, Glenda L Wrenn, Paul Crits-Christoph.   

Abstract

BACKGROUND: The NIDA Collaborative Cocaine Treatment Study yielded different efficacies for different psychosocial treatments for cocaine dependence. However, substantial heterogeneity of patient outcomes was evident. Longitudinal data analysis techniques can be helpful in examining differential effects of psychosocial interventions on specific subpopulations of patients.
METHODS: Overall drug and cocaine use of 346 patients diagnosed with DSM-IV cocaine dependence and treated with one of four psychosocial interventions were assessed monthly during 6-month treatment. Growth mixture models were used to identify patient subgroups based on typical patterns of change in substance use during treatment and to evaluate differential treatment effects within these subgroups.
RESULTS: Three patient subgroups following different change patterns in cocaine and overall drug use were identified irrespective of the treatment type: (a) those with moderate baseline severity of drug use and very rapid reduction of drug use during treatment, (b) those with moderate baseline severity of drug use and moderate reduction of drug use during treatment, and (c) those with severe levels of baseline drug use with moderate reduction of drug use during treatment. Patient baseline characteristics enabled discrimination between these subgroups. Individual drug counseling was most efficacious among those patients with moderate baseline severity and moderate treatment response. There were no differential treatment effects in the two other patient subgroups.
CONCLUSIONS: The population of treatment-seeking cocaine dependent individuals is heterogeneous. Research on patient subgroups with different change patterns revealed its potential to enable classifications of patients that indicate which treatment is most effective for which type of patient. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19782480      PMCID: PMC2814930          DOI: 10.1016/j.drugalcdep.2009.08.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  36 in total

1.  Mediators of outcome of psychosocial treatments for cocaine dependence.

Authors:  Paul Crits-Christoph; Mary Beth Connolly Gibbons; Jacques P Barber; Robert Gallop; Aaron T Beck; Delinda Mercer; Xin Tu; Michael E Thase; Roger D Weiss; Arlene Frank
Journal:  J Consult Clin Psychol       Date:  2003-10

2.  General growth mixture modeling for randomized preventive interventions.

Authors:  Bengt Muthén; C Hendricks Brown; Katherine Masyn; Booil Jo; Siek-Toon Khoo; Chih-Chien Yang; Chen-Pin Wang; Sheppard G Kellam; John B Carlin; Jason Liao
Journal:  Biostatistics       Date:  2002-12       Impact factor: 5.899

3.  Natural classes of treatment response.

Authors:  A R Morral; M Y Iguchi; M A Belding; R J Lamb
Journal:  J Consult Clin Psychol       Date:  1997-08

Review 4.  Recent advances in the psychotherapy of addictive disorders.

Authors:  Kathleen M Carroll
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

5.  Profiles of drug use behavior change for adolescents in treatment.

Authors:  Holly Barrett Waldron; Charles W Turner; Timothy J Ozechowski
Journal:  Addict Behav       Date:  2005-10-03       Impact factor: 3.913

6.  Shapes of early change in psychotherapy under routine outpatient conditions.

Authors:  Niklaus Stulz; Wolfgang Lutz; Chris Leach; Mike Lucock; Michael Barkham
Journal:  J Consult Clin Psychol       Date:  2007-12

7.  Patient profiling: an application of random coefficient regression models to depicting the response of a patient to outpatient psychotherapy.

Authors:  W Lutz; Z Martinovich; K I Howard
Journal:  J Consult Clin Psychol       Date:  1999-08

8.  Exploring individual change.

Authors:  M S Krause; K I Howard; W Lutz
Journal:  J Consult Clin Psychol       Date:  1998-10

9.  Evaluation of psychotherapy. Efficacy, effectiveness, and patient progress.

Authors:  K I Howard; K Moras; P L Brill; Z Martinovich; W Lutz
Journal:  Am Psychol       Date:  1996-10

10.  Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders.

Authors:  Wolfgang Lutz; Niklaus Stulz; Katharina Köck
Journal:  J Affect Disord       Date:  2009-02-14       Impact factor: 4.839

View more
  6 in total

1.  Psychosocial treatments for cocaine dependence: the role of depressive symptoms.

Authors:  Niklaus Stulz; Michael E Thase; Robert Gallop; Paul Crits-Christoph
Journal:  Drug Alcohol Depend       Date:  2011-03-01       Impact factor: 4.492

Review 2.  Treatment of substance abusing patients with comorbid psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  Addict Behav       Date:  2011-09-14       Impact factor: 3.913

3.  Patterns of early change and their relationship to outcome and early treatment termination in patients with panic disorder.

Authors:  Wolfgang Lutz; Stefan G Hofmann; Julian Rubel; James F Boswell; M Katherine Shear; Jack M Gorman; Scott W Woods; David H Barlow
Journal:  J Consult Clin Psychol       Date:  2014-01-20

Review 4.  Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction.

Authors:  Maggie M Sweitzer; Eric C Donny; Ahmad R Hariri
Journal:  Drug Alcohol Depend       Date:  2012-02-16       Impact factor: 4.492

5.  Lending an ear to feedback systems: evaluation of recovery and non-response in psychotherapy in a German outpatient setting.

Authors:  Wolfgang Lutz; Jan R Böhnke; Katharina Köck
Journal:  Community Ment Health J       Date:  2010-04-27

Review 6.  A "SMART" design for building individualized treatment sequences.

Authors:  H Lei; I Nahum-Shani; K Lynch; D Oslin; S A Murphy
Journal:  Annu Rev Clin Psychol       Date:  2011-12-12       Impact factor: 18.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.